Nabeel Mohsin Akhter, MBBS

Nabeel Akhter practices at Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center.

Nabeel Akhter's NPI, 1487847075, was assigned on August 27, 2007. Nabeel Akhter holds Maryland license D0074054.

Nabeel Akhter's primary practice is Mercy Medical Center, at 301 Saint Paul Place, Baltimore, MD 21202 in Baltimore City. The practice phone is (410) 332-9237.

Nabeel Akhter's primary practice is Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center. Nabeel Akhter is also affiliated with University of Maryland Medical Center. The medical group on file is Mercy Personal Physicians Downtown. Dmand AI also links Nabeel Akhter to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nabeel Akhter practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Nabeel Akhter's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Nabeel Akhter is licensed in Maryland.

CMS data shows 1,763 Medicare services from Nabeel Akhter across 42 procedure codes in 2024, for 1,187 Medicare patients. Medicare paid $74,615 for them.

CMS counts 1,187 Medicare patients who saw Nabeel Akhter in 2024. The largest group is 65 to 74, with 567 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nabeel Akhter's median patient age at 68, with 61% women.

In 2024, Nabeel Akhter wrote 84 Medicare Part D claims for 32 patients. 92% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $526 in total drug cost. In 2023, CMS named 68 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Nabeel Akhter for performance year 2024, reported as part of a group. Nabeel Akhter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nabeel Akhter as offering telehealth.

Dmand AI links 14 papers to Nabeel Akhter, published from 2019 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Liver Neoplasms and Yttrium Radioisotopes. Nabeel Akhter has published most often in J Clin Imaging Sci. Nabeel Akhter's most frequent co-authors are Sheena Chandra Anand, MD, Jayson S. Brower, MD and Vikash Gupta, MD.

Dmand AI links Nabeel Akhter to 1 clinical trial. Conditions studied include Carcinoma, Hepatocellular and Liver Neoplasms.

CMS Open Payments shows 115 general payments to Nabeel Akhter from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 48% of the total. Boston Scientific Corporation paid the most, $6,188.